Diabetes-related Changes in cAMP Response Element-binding Protein Content Enhance Smooth Muscle Cell Proliferation and Migration

• Published in: The Journal of biological chemistry Vol. 276; no. 49; pp. 46142 - 46150
• Main Authors: Watson, Peter A., Nesterova, Albina, Burant, Charles F., Klemm, Dwight J., Reusch, Jane E.-B.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 07-12-2001; American Society for Biochemistry and Molecular Biology
• Subjects: Animals; Antioxidants - pharmacology; Blotting, Western; Cattle; Cell Division - physiology; Cell Movement - physiology; Cells, Cultured; CREB-Binding Protein; Diabetes Mellitus, Experimental - metabolism; Diabetes Mellitus, Experimental - pathology; Glucose - administration & dosage; Insulin Resistance; Muscle, Smooth, Vascular - drug effects; Muscle, Smooth, Vascular - metabolism; Muscle, Smooth, Vascular - pathology; Nuclear Proteins - metabolism; Nuclear Proteins - physiology; Oxidative Stress; Rats; Trans-Activators - metabolism; Trans-Activators - physiology
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.M104770200

We hypothesized that diabetes and glucose-induced reactive oxygen species lead to depletion of cAMP response element-binding protein (CREB) content in the vasculature. In primary cultures of smooth muscle cells (SMC) high medium glucose decreased CREB function but increased SMC chemokinesis and entry into the cell cycle. These effects were blocked by pretreatment with the antioxidants. High glucose increased intracellular reactive oxygen species detected by CM-H2DCFA. SMC exposed to oxidative stress (H2O2) demonstrated a 3.5-fold increase in chemokinesis (p < 0.05) and accelerated entry into cell cycle, accompanied by a significant decrease in CREB content. Chronic oxidative challenge similar to the microenvironment in diabetes (glucose oxidase treatment) decreases CREB content (40–50%). Adenoviral-mediated expression of constitutively active CREB abolished the increase in chemokinesis and cell cycle progression induced by either high glucose or oxidative stress. Analysis of vessels from insulin resistant or diabetic animals indicates that CREB content is decreased in the vascular stroma. Treatment of insulin-resistant animals with the insulin sensitizer rosiglitazone restores vessel wall CREB content toward that observed in normal animals. In summary, high glucose and oxidative stress decrease SMC CREB content increase chemokinesis and entry into the cell cycle, which is blocked by antioxidants or restoration of CREB content. Thus, decreased vascular CREB content could be one of the molecular mechanisms leading to increased atherosclerosis in diabetes.